Quantification and genotyping in management of chronic hepatitis B and C
- PMID: 11885949
- DOI: 10.1016/s0168-1702(01)00386-0
Quantification and genotyping in management of chronic hepatitis B and C
Similar articles
-
Clinical impact of hepatitis B and C virus envelope glycoproteins.World J Gastroenterol. 2013 Feb 7;19(5):654-64. doi: 10.3748/wjg.v19.i5.654. World J Gastroenterol. 2013. PMID: 23429668 Free PMC article. Review.
-
Measuring immunity in viral hepatitis.J Gastroenterol. 2004 Aug;39(8):709-16. doi: 10.1007/s00535-004-1395-9. J Gastroenterol. 2004. PMID: 15338363 Review. No abstract available.
-
Perspectives on the management of chronic hepatitis B and C.Expert Rev Anti Infect Ther. 2009 Apr;7(3):243-7. doi: 10.1586/eri.09.16. Expert Rev Anti Infect Ther. 2009. PMID: 19344237 No abstract available.
-
Virological techniques for the diagnosis and monitoring of hepatitis B and C.Ann Hepatol. 2009 Jan-Mar;8(1):7-12. Ann Hepatol. 2009. PMID: 19221527 Review. No abstract available.
-
[Protocol for the treatment of chronic viral hepatitis].Orv Hetil. 2008 Jan 20;149(3):129-35. doi: 10.1556/OH.2008.28287. Orv Hetil. 2008. PMID: 18194921 Hungarian. No abstract available.
Cited by
-
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers.Virol J. 2011 Feb 27;8:86. doi: 10.1186/1743-422X-8-86. Virol J. 2011. PMID: 21352567 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources